You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult multiple myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Relapsed/Refractory Multiple Myeloma Trial (Isatuximab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • (no location specified)
Feb 3, 2023

Solid Tumors, Adult, Multiple Myeloma, Lymphoma Trial in San Antonio (VP301)

Recruiting
  • Solid Tumors, Adult
  • +2 more
  • San Antonio, Texas
    NEXT Oncology
Jan 16, 2023

Plasma Cell Myeloma Trial (Isatuximab (SAR650984), Cemiplimab (SAR439684), Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • Isatuximab (SAR650984)
  • +4 more
  • (no location specified)
Feb 1, 2023

Advanced Solid Tumor, Adult Disease, Multiple Myeloma Trial in Spain, Switzerland, United Kingdom (ANV419, CPI or

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Barcelona, Spain
  • +4 more
Dec 19, 2022

Multiple Myeloma, Relapsed Cancer, Refractory Multiple Myeloma Trial (ANV419, Lenalidomide with low-dose dexamethasone,

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • (no location specified)
Nov 29, 2022

Multiple Myeloma Trial in Worldwide (PHE885)

Recruiting
  • Multiple Myeloma
  • PHE885
  • VIC, Melbourne, Australia
  • +4 more
Jul 20, 2022

Multiple Myeloma Trial in Chicago, Boston, Milwaukee (PHE885)

Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +4 more
Jul 28, 2022

Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Kashiwa-shi, Chiba, Japan
  • +5 more
Jan 25, 2023

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in United States (REGN5459)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Indianapolis, Indiana
  • +6 more
Aug 16, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Multiple Myeloma (MM)
  • 3x10(6) CART-38 cellls
  • +5 more
  • (no location specified)
Jul 15, 2022

Multiple Myeloma Trial in Zhengzhou (PD1-BCMA-CART)

Not yet recruiting
  • Multiple Myeloma
  • PD1-BCMA-CART
  • Zhengzhou, Henan, China
    First Affliated Hospital of Zhengzhou University
May 15, 2022

Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, Acute Lymphoblastic Leukemia, Adult Trial in Atlanta (Fludarabine,

Not yet recruiting
  • Non-hodgkin Lymphoma,B Cell
  • +2 more
  • Atlanta, Georgia
    Caitlin Guzowski
Jun 9, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

Recruiting
  • Lymphoma
  • +3 more
  • New York, New York
    Columbia University
Apr 27, 2022

Multiple Myeloma Trial in Worldwide (ABBV-383)

Not yet recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +12 more
Dec 6, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 7, 2022

Biospecimen Procurement for Center for Immuno-Oncology

Recruiting
  • Multiple Myeloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 13, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +11 more
    • Health Promotion and Education
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 24, 2023

    Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Denver, Colorado
    • +8 more
    May 19, 2022

    Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +4 more
    • Autologous CAR-T cells
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Pudong Hospital, Fudan University Affiliated Pudong Med
    Aug 22, 2022

    Multiple Myeloma Trial in Boston, New York, Charlotte (NMS-03597812, NMS-03597812 + dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Boston, Massachusetts
    • +2 more
    Aug 25, 2021

    Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult B-Cell
    • +3 more
    • clonoSEQ Assay
    • Stanford, California
    • +15 more
    Jan 30, 2023

    Multiple Myeloma Treated With Intravenous Bisphosphonate in

    Recruiting
    • Multiple Myeloma
    • Blood and urine collection
    • Paris, France
      Necker Hospital, Adult haematology department
    Oct 1, 2021